|
|
| Industrie Pharmaceutique > Etude de marché sectorielle |
|
|
|
|
€ 1 917,00 |
Editeur
: |
Global Industry Analyst |
Langue
: |
Anglais |
Date de publication : |
Juillet 2005 |
Taille du document : |
253 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
|
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
MarketWatch: Health Round-up
48 pages | |
Datamonitor's MarketWatch Health Round-up is a one-stop news shop for time-pressed executives.
It provides monthly insight into the key events in the Healthcare industry.
The report contains the |
320,00 €
|
| |
| |
The Evolution of DTC marketing across key pharmaceutical markets
152 pages | Mars 2000 |
Pharmaceutical companies mainly market their products through contact between their sales force and heathcare providers.
However, due to the nature of its products, the pharmaceutical industry |
955,00 €
|
| |
| |
Maximising the Drug Lifecycle
102 pages | Août 2001 |
Up to $100bn of the 2000 pharmaceutical market, including blockbuster drugs with combined sales of $34bn will be exposed to generic competition by 2005.Maximising The Drug Lifecycle provides a detaile |
955,00 €
|
| |
| |
MarketWatch: CNS
25 pages | |
Datamonitor's CNS MarketWatch is a one-stop news shop for timepressed executives.
It provides monthly insight into the key events in the CNS industry.
The report contains the latest news, analys |
160,00 €
|
| |
| |
The Drug Delivery Outlook to 2005
150 pages | Février 1999 |
Strategic overview : defines and values the market covered in the report, provides a macro analysis of the reasons why the drug delivery sector is growing at current rates and predicts how the c |
795,00 €
|
| |
| |
Stakeholder Opinions: Novel Therapeutic Approaches in Cardiovascular Medicine - Lack of market prospects for biologics expose an opportunity for cell and gene therapies
162 pages | |
IntroductionAt the forefront of novel technologies; momentum is steadily building for the development of stem cell products to address cardiovascular disease.
The most active areas are those with h |
6 080,00 €
|
| |
| |
The Diagnostics Outlook to 2005
130 pages | Février 1999 |
Diagnostic market : The current in vitro diagnostic (IVD) market is discussed, identifying how the market can be segmented according to country, end user, clinical speciality and disease area.
795,00 €
|
|
| |
| |
The Pharmacogenomics Outlook
174 pages | Août 2000 |
Pharmaceutical companies are coming under increasing pressure to increase the quality of their products, and optimize and accelerate drug discovery and development.
By identifying differenc |
955,00 €
|
| |
| |
The Cardiovascular Outlook 1998-2010
186 pages | Août 1999 |
In 1998, the global cardiovascular market expanded by 7.2%, growing in value from $60bn in 1997 to almost $65bn in 1998.
Market expansion is being driven by expanding prevalent populations in t |
795,00 €
|
| |
| |
Wyeth: PharmaVitae Profile
158 pages | |
IntroductionThis analysis examines the historical and forecast performance for Wyeth in the prescription pharmaceutical sector.
The profile encompasses global company strategy, portfolio and pipeli |
4 560,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
|
|
This report analyzes the worldwide markets for Peptic Ulcers Testing in Millions of US$. The specific product segments analyzed are Peptic Ulcer Testing. The report provides separate comprehensive analytics for the US, Japan, Europe, Asia-Pacific (excluding Japan), and Latin America. Annual forecasts are provided for each region and product segment for the period of 2001 through 2010. A ten-year historic analysis is also provided for these markets with annual market analytics. The report profiles 35 companies including many key and niche players worldwide such as Beckman Coulter, Meretek, Meridian Bioscience, Inc., Noster System AB, Orion Diagnostica, and Quidel Corporation.
|
|
|
PPLSEN
|
|
|
|
|
